123 related articles for article (PubMed ID: 20496073)
1. Molecular characterization of early adenocarcinoma of the uterine cervix by oligonucleotide microarray.
Liao LM; Zheng M; Huang L; Ding H; He L; Zhang Y; Wang HY
Arch Gynecol Obstet; 2011 Apr; 283(4):861-9. PubMed ID: 20496073
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
[TBL] [Abstract][Full Text] [Related]
3. [Adenocarcinoma of the cervix uteri].
Frank GA; Andreeva IuIu; Zavalishina LE; Petrov AN
Arkh Patol; 1999; 61(5):61-5. PubMed ID: 10598265
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity.
Bachtiary B; Boutros PC; Pintilie M; Shi W; Bastianutto C; Li JH; Schwock J; Zhang W; Penn LZ; Jurisica I; Fyles A; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5632-40. PubMed ID: 17020965
[TBL] [Abstract][Full Text] [Related]
5. DNA aneuploidy in invasive carcinoma of the uterine cervix.
Kashyap V; Bhambhani S
Indian J Pathol Microbiol; 2000 Jul; 43(3):265-9. PubMed ID: 11218670
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of adenocarcinoma of the cervix.
Parker MF; Arroyo GF; Geradts J; Sabichi AL; Park RC; Taylor RR; Birrer MJ
Gynecol Oncol; 1997 Feb; 64(2):242-51. PubMed ID: 9038270
[TBL] [Abstract][Full Text] [Related]
7. [Pathological anatomy of adenocarcinoma of the cervix].
De Agustín P; Claver M; Gutiérrez M; Segura A
Acta Obstet Ginecol Hisp Lusit; 1972 Jun; 20(4):257-66. PubMed ID: 4643266
[No Abstract] [Full Text] [Related]
8. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression.
Chao A; Wang TH; Lee YS; Hsueh S; Chao AS; Chang TC; Kung WH; Huang SL; Chao FY; Wei ML; Lai CH
Int J Cancer; 2006 Jul; 119(1):91-8. PubMed ID: 16450401
[TBL] [Abstract][Full Text] [Related]
10. [Glandular epithelioma of the uterine cervix].
Lefakis P; Schuh D; Rousselot P; Philippe E
Ann Anat Pathol (Paris); 1968; 13(1):69-86. PubMed ID: 5674247
[No Abstract] [Full Text] [Related]
11. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
Jaworski RC
Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters.
Bodner K; Laubichler P; Kimberger O; Czerwenka K; Zeillinger R; Bodner-Adler B
Anticancer Res; 2010 Apr; 30(4):1341-5. PubMed ID: 20530450
[TBL] [Abstract][Full Text] [Related]
13. [Significance of c-erbB-2 and PCNA expression in adenocarcinoma of uterine cervix].
Huang Y; Cai S; Yu S
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):150-2. PubMed ID: 10743084
[TBL] [Abstract][Full Text] [Related]
14. [Villoglandular adenocarcinoma of the cervix uteri. A case report and analysis of the literature].
Wiesenfeld U; Baraggino E; Melato M
Minerva Ginecol; 1997 May; 49(5):221-4. PubMed ID: 9304084
[TBL] [Abstract][Full Text] [Related]
15. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness.
Yoon SO
Hum Pathol; 2007 Feb; 38(2):326-31. PubMed ID: 17137614
[TBL] [Abstract][Full Text] [Related]
16. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
[TBL] [Abstract][Full Text] [Related]
17. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
Faried LS; Faried A; Kanuma T; Aoki H; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Mol Carcinog; 2008 Jun; 47(6):446-57. PubMed ID: 18058806
[TBL] [Abstract][Full Text] [Related]
18. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri.
Krumins I; Young Q; Pacey F; Bousfield L; Mulhearn L
Acta Cytol; 1977; 21(2):320-9. PubMed ID: 266347
[No Abstract] [Full Text] [Related]
19. Cervical adenocarcinoma identification by testing for chromosomal abnormalities.
Dittus JL; Dudley BS; Upender M; Endress GA
Arch Pathol Lab Med; 2013 Dec; 137(12):1829-31. PubMed ID: 24283864
[TBL] [Abstract][Full Text] [Related]
20. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
